Welcome to this T2DM CME Snapshot™ video series. Each 15-minute module offers focused education for endocrinologists and primary care providers with actionable recommendations on injectable noninsulin antihyperglycemic agents for T2DM. For a comprehensive curriculum that provides interactive discussions on recent evidence related to glucagon-like peptide-1 receptor agonists (GLP-1 RAs), clinician learners can complete all 4 modules and receive a full hour of AMA PRA Category 1 Credit™.

Jointly provided by the Elsevier Office of Continuing Medical Education, Dannemiller, and Integritas Communications.

 

This activity has been supported by independent educational grants from Novo Nordisk Inc.

modules
SnapShot 
0.25 CME/CE

Clinical Profiles of Current and Emerging GLP-1 RAs

Begin Activity
SnapShot 
0.25 CME/CE

Reducing Cardiovascular Risk in Patients with T2DM

Begin Activity
SnapShot 
0.25 CME/CE

Overcoming Barriers to Injectable Noninsulin Therapies

Begin Activity
SnapShot 
0.25 CME/CE

Practical Recommendations for Noninsulin Injectable Therapies

Begin Activity